3rd Circ. Shuns Teva's 'Novel' Appeal On Israeli Investor Class

By Jessica Corso · May 16, 2024, 8:48 PM EDT

The Third Circuit on Thursday turned away an appeal brought by Teva Pharmaceutical Industries Ltd., saying the class certification stage was not the right time to hear arguments over the "novel"...

To view the full article, register now.